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INTRODUCTION
Overactive bladder (OAB) is a prevalent cause of lower urinary 
tract symptoms (LUTS) defined as a syndrome of bladder stor-
age function and characterized by a cluster of symptoms in-
cluding urinary urgency, frequency, and nocturia with or with-
out urinary incontinence [1]. Symptoms of OAB may have a 
detrimental impact on patients’ quality of life (QoL) and could 
lead to emotional distress, depression, anxiety, and sleep distur-
bances [2]. Multiple urological and nonurological risk factors 
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Purpose: Overactive bladder (OAB) symptoms might be affected by weather, but only a few clinical studies have investigated 
this issue. We investigated seasonal variations in OAB-drug prescription rate (DPR) in men using nationwide claims data in 
Korea. 
Methods: A total of 2,824,140 men aged over 18 years were included from the Health Insurance Review and Assessment ser-
vice – National Patient Sample data between 2012 and 2016. Depending on the monthly average temperature, the seasons 
were divided into 3 groups, namely, hot (June, July, August, and September), intermediate (April, May, October, and Novem-
ber), and cold (January, February, March, and December) seasons. OAB-DPR was estimated using the claims data, and differ-
ences in its rate were examined among the 3 seasonal groups. 
Results: The overall OAB-DPR was 1.97% (55,574 of 2,824,140). The OAB-DPR were 0.38%, 0.63%, 0.92%, 1.74%, 4.18%, 
7.55%, and 9.69% in the age groups of under 30, 30s, 40s, 50s, 60s, 70s, and over 80 years, respectively; thus, the prescription 
rate increased with age (P<0.001), with a steeper increase after 60 years of age. OAB-DPR was 1.02% in the hot season, 1.19% 
in the intermediate season, and 1.27% in the cold season, with significant differences among the 3 seasonal groups (P<0.001). 
These seasonal variations persisted in the subgroup analysis in each age decade (P<0.001). 
Conclusions: OAB-DPR varied with seasons and was significantly higher in the cold season than in the hot season, suggest-
ing that cold weather may affect development and aggravation of OAB symptoms in men.
Keywords: Men; Seasons; Urinary bladder, Overactive
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are associated with the development of OAB, such as age, obe-
sity, cognitive disorders, metabolic syndrome, neurologic disor-
ders, and benign prostatic hyperplasia (BPH) [3]. 
There is also a widely held perception that LUTS vary in se-
verity with seasonal changes, and, in particular, that they wors-
en in cold weather. According to the 5-year BPH patient-based 
dataset (2008–2012) of National Health Insurance in Korea, 
seasonal variations of visiting hospital patients are seen between 
summer and winter [4]. Several studies have addressed the as-
sociations between seasonal variations and LUTS. Yoshimura et 
al. [5] revealed that winter is an independent risk factor for uri-
nary frequency, urgency, and nocturia. Choi et al. [6] also re-
ported that seasonal variations are meaningfully associated 
with LUTS, particularly storage symptoms. Kobayashi et al. [7] 
demonstrated a significant seasonal difference in nocturia only, 
which showed a higher score in winter; however, no seasonal 
difference was seen in uroflowmetric parameters. However, 
Cartwright et al. [8] reported no significant variation in the uri-
nary symptom scores or uroflowmetric parameters with chang-
es in season. Watanabe et al. [9] also reported no seasonal dif-
ferences in the urinary symptom scores, although maximum 
flow rate (Qmax) could be influenced by seasonal changes. On 
the other hand, Tae et al. [10] demonstrated that female OAB 
symptoms might be worse during cold season than in other 
seasons. As seen in the aforementioned studies, seasonal varia-
tion might be related to storage symptoms, but such a relation-
ship remains controversial. To obtain robust evidence on this 
issue, we investigated seasonal variations in OAB-drug pre-
scription rate (DPR) in men using nationwide claims data.
MATERIALS AND METHODS
1. Data sources and Study Sample
In South Korea, the National Health Insurance is a universal 
health coverage system that covers approximately 100% of Ko-
rean residents. The claims data of Health Insurance Review 
Agency (HIRA) is collected when healthcare service providers 
submit a claim to HIRA for reimbursement for a service that 
they provided to patients. The HIRA claims data represent 46 
million patients each year, accounting for 90% of the total pop-
ulation in Korea. However, given the complexity and large vol-
ume of the dataset, its use is typically restricted to researchers. 
To resolve these limitations and increase the efficiency of data 
use, the HIRA developed patient sample data that passed valid-
ity tests performed by 5 different institutions [11]. Here, we 
used the national patient sample (NPS) of the HIRA claims 
data (HIRA-NPS) comprising randomized patients who used 
the National Health System at least once a year. This dataset 
passed validity tests performed by 5 different institutions and 
included 1.4 million patients overall per year (3%) [11]. In this 
study, we used HIRA-NPS, 2012–2016, from which all men 
aged over 18 years were included.
2. Climate Data and Seasonal Groups
South Korea’s location is 38°N, 127° 30' E; it is within a temper-
ate climate region. Climate data were extracted from the Korea 
Meteorological Administration, and mean monthly tempera-
tures were calculated (Table 1). According to the monthly aver-
age temperature, the seasons were divided into 3 groups: hot 
(June, July, August, and September), intermediate (April, May, 
October, and November), and cold (January, February, March, 
and December) seasons. 
3. Definition of OAB 
All available OAB drugs in Korea such as fesoterodine, imidafe-
nacin, mirabegron, oxybutynin, propiverine, solifenacin, tolt-
erodine, and trospium were included (Supplementary Table 1). 
OAB-DPR was calculated as the number of patients who were 
Table 1. Monthly average temperature in South Korea from 2012 to 2016
Year
Temperature (°C)
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2012 -1.2 -0.8 5.7 12.6 18.3 22.1 25.5 26.4 20.2 14.3 6.6 -1.7
2013 -2.1 0.7 6.6 10.3 17.8 22.6 26.3 27.3 21.2 15.4 7.1 1.5
2014 0.5 2.5 7.7 13.4 18.4 21.9 25.1 23.8 20.9 14.8 8.8 -0.5
2015 0.5 2 6.7 12.7 18.6 21.7 24.4 25.2 20.5 15 10.1 3.5
2016 -0.9 1.7 7.2 13.8 18.6 22.3 25.4 26.7 21.6 15.8 7.8 3.1
Totala) -0.6±1.0 1.2±1.2 6.8±0.7 12.6±1.2 18.3±0.3 22.1±0.3 25.3±0.6 25.9±1.2 20.9±0.5 15.6±0.5 8.1±1.3 1.2±2.0
a)Values are presented as mean±standard deviation.
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prescribed OAB drug among all patients during a certain peri-
od. The overall prescription rate was calculated, followed by the 
prescription rate according to the age and seasonal group. 
4. Statistical Analysis
The chi-square test was used to investigate the association be-
tween OAB-DPR and seasonal variation. Logistic regression was 
used to assess the effect of each season on OAB-DPR, and odds 
ratios (ORs) and 95% confidence intervals (CI) were calculated. 
P values of ≤0.05 were considered statistically significant. All 
statistical analyses were performed using IBM SPSS Statistics 
ver. 25.0 (IBM Co., Armonk, NY, USA).
RESULTS
Of the total 7,223,663 people, 5,885,483 (81.48%) were aged 
over 18 years. Among them, 2,824,158 (47.99%) were men, and 
their mean age was 45.8±16.4. A total of 55,574 men (1.97%) 
were prescribed OAB drug once between 2012 and 2016, and 
their mean age was 62.4±15.3 (Fig. 1). OAB-DPR by age group 
was 0.38% in those under 30 years, 0.63% in those in their 30s, 
0.92% in those in their 40s, 1.74% in those in their 50s, 4.18% 
in those in their 60s, 7.55% in those in their 70s, and 9.69% in 
those over 80 years (Table 2). Thus, the prescription rate in-
creased with age, with a steeper increase after 60 years of age 
(Fig. 2). 
In the present study, the seasons were divided into 3 groups 
as hot, intermediate, and cold seasons. The average tempera-
tures were 23.6°C±2.3°C in the hot season, 13.5°C±4.0°C in 
the intermediate season, and 2.1°C±3.2°C in the cold season. 
There were significant differences in OAB-DPR among the sea-
sonal groups, with the prescription rate being 1.02% (reference) 
in the hot season, 1.19% (OR, 1.170; 95% CI, 1.152–1.189) in 
the intermediate season, and 1.27% (OR, 1.244; 95% CI, 1.225–
1.264) in the cold season (P<0.001) (Table 3). These seasonal 
variations persisted in the subgroup analysis of age decades 
(P<0.001) (Table 3).
DISCUSSION
Seasons of the year exerts an influence on certain disease condi-
tions, such as coronary heart disease, cerebrovascular disease, 
and respiratory disease [12-14]. Our study demonstrated that 
OAB-DPR also varies among seasons: Specifically, it was signif-
icantly higher in the cold season than in the hot season, sug-
gesting that cold weather may develop and aggravate OAB 
symptoms in men. This seasonal variation was consistently ob-
Fig. 1. Case extraction diagram. HIRA, Health Insurance Re-






























Fig. 2. Drug prescription rate for overactive bladder in men ac-
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served in each age group. To the best of our knowledge, our 
study is the first report to investigate the relationship between 
seasonal variation and OAB-DPR using a nationwide dataset. 
The presumptive explanation of this observation is as follows: 
the first is the response of the muscles to the cold stress. Cold 
stress increases sympathetic activity, which stimulates smooth 
Table 2. Drug prescription rate for OAB according to age decades
Age (yr) Total patients Patient with OAB (%)
Chi-square value
<30 30s 40s 50s 60s 70s
<30 542,804 2,043 (0.38)
30–39 529,636 3,332 (0.63) 339.9***
40–49 593,346 5,476 (0.92) 1,271.3*** 310.4***
50–59 563,157 9,782 (1.74) 4,837.4*** 2,825.5*** 1,470.8***
60–69 335,422 14,025 (4.18) 16,710.3*** 13,179.2*** 11,067.9*** 4,869.6***
70–79 199,064 15,036 (7.55) 33,355.8*** 28,231.9*** 25,987.7*** 15,795.5*** 2,762.7***
≥80 60,711 5,880 (9.69) 36,521.8*** 29,080.7*** 24,785.4*** 14,146.0*** 3,263.1*** 285.6***
OAB, overactive bladder.
***P<0.001 by Pearson chi-square test.
Table 3. Drug prescription rate for OAB according to the seasonal groups and age decades
Age Total patients Season Patients with OAB (%)
Logistic regression analysis
Odd ratio 95% CI P-value
Total 2,824,141 Hot 28,849 (1.02) Reference <0.001
Intermediate 33,698 (1.19) 1.170 1.152–1.189
Cold 35,802 (1.27) 1.244 1.225–1.264
<30 542,804 Hot 754 (0.14) Reference <0.001
Intermediate 883 (0.16) 1.171 1.063–1.291
Cold 975 (0.18) 1.294 1.176–1.423
30s 529,636 Hot 1,349 (0.25) Reference <0.001
Intermediate 1,549 (0.29) 1.149 1.068–1.236
Cold 1,597 (0.30) 1.184 1.101–1.274
40s 593,346 Hot 2,258 (0.38) Reference <0.001
Intermediate 2,820 (0.48) 1.250 1.183–1.321
Cold 2,944 (0.50) 1.305 1.236–1.379
50s 563,157 Hot 4,582 (0.81) Reference <0.001
Intermediate 5,494 (0.98) 1.201 1.155–1.249
Cold 6,090 (1.08) 1.333 1.282–1.385
60s 335,422 Hot 7,628 (2.27) Reference <0.001
Intermediate 8,859 (2.64) 1.166 1.130–1.202
Cold 9,588 (2.86) 1.265 1.227–1.304
70s 199,064 Hot 8,732 (4.39) Reference <0.001
Intermediate 10,082 (5.06) 1.163 1.129–1.197
Cold 10,494 (5.27) 1.213 1.178–1.249
≥80 60,711 Hot 3,546 (5.84) Reference <0.001
Intermediate 4,011 (6.61) 1.140 1.088–1.195
Cold 4,114 (6.78) 1.172 1.119–1.227
OAB, overactive bladder; CI, confidence interval.
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muscle contraction in the prostate, and induces detrusor over-
activity, which decreases voiding interval and volume [15,16]. 
The second is the change in diuresis with temperature. Diuresis 
is reduced by insensible fluid loss from sweating at high tem-
peratures [17]. On the contrary, cold stress not only provokes 
peripheral vasoconstriction, which inhibits vasopressin secre-
tion and leads to diuresis [18], but also stimulates the secretion 
of plasma atrial natriuretic peptide, which enhances diuresis 
[19]. The third is seasonal variation in vitamin D levels. Increas-
ing evidence suggests that vitamin D deficiency or insufficiency 
is associated with LUTS [20]. Vitamin D status was found to be 
an independent significant predictor of OAB, with an increase 
of OAB risk by 44 times in patients with severe vitamin D defi-
ciency [21]. The incidence of vitamin D deficiency was signifi-
cantly higher during the winter than the summer [22,23]. These 
results suggest that seasonal changes in vitamin D influence 
seasonal OAB development.
In previous studies, seasonal variation was more pronounced 
in storage symptoms than in voiding symptoms (Table 4) [5-7]. 
The Japanese Urological Association recommends conservative 
treatment in which men with LUTS avoid exposing their lower 
body to cold temperatures [24]. A large retrospective study by 
Choi et al. [6] demonstrated that symptom severity as mea-
sured using the International Prostate Symptom Score (IPSS) 
was worse in the cold season group than in the hot season 
group. Storage symptom scores were significantly worse in the 
cold, and the QoL score showed a significant difference be-
tween the cold and hot seasons. In uroflowmetric parameters, 
voided volume and postvoid residue exhibited a significant sea-
sonal change, but there was no significant difference in Qmax. 
Kobayashi et al. [7] announced that nocturia had seasonal vari-
ation in patients with BPH; however, there were no seasonal 
variation in the other IPSS categories and uroflowmetric pa-
rameters. Yoshimura et al. [5] performed a large community-
based questionnaire study in Japan including 3 towns (Tobetsu 
at higher latitude [43°N], Kumiyama at middle latitude [35°N], 
and Sashiki at lower latitude [26°N]) and reported that 3 stor-
age symptoms (frequency, urgency, and nocturia) demonstrat-
ed significant differences between summer and winter; such a 
difference was observed in relatively low latitude areas (Kumi-
yama and Sashiki) but not in higher latitude areas (Tobetsu). 
Likewise, a prospective study performed in Edinburgh, United 
Kingdom, showed no seasonal variation in urinary symptoms 
and uroflowmetric parameters [8]. Edinburgh is located at a 
relatively high latitude (55°N). These findings suggested that 
climate can influence seasonal variations in LUTS. Watanabe et 
al. [9] also explored changes in IPSS and uroflowmetric param-
eters associated with seasonal changes in 31 men with LUTS 
and found no significant seasonal change in IPSS or QoL but 
reported that Qmax exhibited a significant seasonal change, 
unlikely to expectation, being higher in the winter than in the 
summer. The authors mentioned that indoor temperatures in 
the winter were higher than outdoor temperatures due to cen-
tral heating, whereas indoor temperatures in the summer were 
lower due to air-conditioning. However, the number of subjects 
was too small to draw concrete results. 
Shim et al. [4] conducted a cross-sectional survey to investi-
gate the association between daily temperature and LUTS in 
men and found that it was not affected by average daily temper-
ature but was affected by diurnal temperature variations. Gori-
unov and Davidov [25] reported that the frequency of acute 
urinary retention (AUR) was affected by day-to-day tempera-
ture fluctuations (≥5°C) or a change in the atmospheric pres-
sure (≥9 hPa) and humidity (≥20%). They studied the effect of 
daily temperature variations on LUTS or AUR and found that 
daily temperature variations did not reflect seasonal variations 
in weather because seasonal changes include not only changes 
in temperature but also those in other climatic factors such as 
humidity and total sunshine. Keller at al. [26] demonstrated 
that AUR was negatively correlated with ambient temperature, 
relative humidity, and rainfall and significantly correlated with 
hours of sunshine and atmospheric pressure. 
In a large cross-sectional, population-based study in Korea, 
questionnaire-based OAB prevalence was 2.9% [27], but most 
studies reported 10%–20% OAB prevalence [2,28,29]. Such dis-
crepancy can be explained by the differences in OAB definition, 
survey questionnaires for OAB, survey methods, and character-
istics of the study populations. In our study, OAB-DPR was 
1.97%. The prescription rate may differ from those prevalence 
rates surveyed, because our study was based on OAB-DPR, not 
on the diagnosis of OAB. This might be a limitation of our 
study, but it suggests that a significant number of patients with 
OAB symptoms require medical help. This study also had other 
limitations. First, since HIRA-NPS is not longitudinal database, 
it was impossible to obtain prior history of OAB diagnosis or 
OAB drug medication. This study did not include detailed clin-
ical data on other comorbidities that could affect OAB. Second, 
the present study was based on OAB-DPR, not on the diagnosis 
of OAB. Third, the study year might be an important variable, 
but there was no difference in seasonal variation for each year 
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(data not shown). Fourth, we performed the analysis using only 
the monthly average temperature of the country instead of us-
ing the temperatures corresponding to actual locations of the 
patients’ residences, although the range of latitude is relatively 
small in Korea. Despite these limitations, our study demon-
strated that seasonal variation affects OAB-DPR, suggesting 
that seasonal changes can affect development of OAB symp-
toms that require medication.
In conclusions, OAB-DPR was affected by seasons, being sig-
nificantly higher in the cold season than in the hot season. This 
suggests that cold weather may affect development and aggra-
vation of OAB symptoms in men. Therefore, it may be helpful 
to consider seasonal changes when managing patients with 
OAB symptoms.
SUPPLEMENTARY MATERIAL
Supplementary Table 1 can be found via https://doi.org/10.5213/
inj.2040030.015. 
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